This study investigated the risk of foot amputation (removal of the foot or part of it) in patients with diabetic foot ulcers to see what factors increase this risk. They found that being male, smoking, and having a history of previous foot ulcers all increased the risk of amputation.  

This study looked at the risk of heart disease, stroke, and other complications in diabetic patients with low thyroid function (hypothyroidism; HT). They found that diabetic patients with HT were not at increased risk of major heart disease or stroke. However, these patients were more likely to develop diabetic eye disease and kidney disease.

This study examined the effectiveness and risks of polyethylene glycol loxenatide (PEX168) as an add-on to metformin (Glucophage) therapy in patients with type 2 diabetes (T2D).

It found that PEX168 is safe and works effectively in improving the blood sugar levels in these patients.

This trial is being carried out to assess the effectiveness of a port delivery system (PDS) loaded with ranibizumab (Lucentis) in order to prevent further progression of diabetic retinopathy (DR; diabetic eye disease). The main outcome of this trial is to assess the improvement in DR following implantation with a PDS. This trial is being carried out in the United States and Puerto Rico. 

This study compared real-time continuous glucose monitoring (CGM) to flash CGM for patients with type 1 diabetes (T1D). It found that real-time CGM led to better glucose control and less hypoglycemia, both during daily activity and exercise.

This study examined the role of statin (cholesterol-lowering) therapy in lowering the risk of diabetic eye disease and sight-threatening complications of diabetes. They found that patients taking a statins were less likely to suffer from advanced diabetic eye disease than those not taking a statin.  

This study analyzed the risk of infections for patients with rheumatoid arthritis (RA) treated with baricitinib (Olumiant). 

The study showed that there is a higher risk of non-serious infections in patients taking baricitinib. 

This study observed the effects of physical activity on patients with chronic inflammatory diseases such as rheumatoid arthritis (RA) by using the supervision of a physiotherapist (PT) and additional digital monitoring.

It showed that the multi-component procedures can help improve pain and the level of daily activity in these patients.

This review looked at the effect of chromium supplements for patients with type 2 diabetes (T2D). It found that chromium supplements improved blood glucose and insulin levels for these patients.

This analysis compared diabetes treatments for how much of the time blood sugar is in the target range. It found that closed-loop systems, which combine a continuous glucose monitor (CGM) and insulin pump, led to better outcomes for people with type 1 diabetes (T1D).